Form 8-K Pulse Biosciences, Inc. For: Oct 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Pulse Biosciences, Inc. (PLSE) Reports Q3 Loss of $0.64
October 30, 2018 4:40 PM EDTPulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.64).
Were pleased with the continued and significant progress weve made and are making towards bringing our NPS platform closer to commercialization, said Darrin Uecker, Pulse Biosciences President and Chief Executive Officer. Our data... More
